Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $67.3200 (1.13%) ($66.3150 - $67.3200) on Tue. Jul. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.13% (three month average) | RSI | 21 | Latest Price | $67.3200(1.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.2% a day on average for past five trading days. | Weekly Trend | LGND declines -1.9% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(47%) IBB(45%) XHB(41%) UNG(37%) VFMO(35%) | Factors Impacting LGND price | LGND will decline at least -1.065% in a week (0% probabilities). UUP(-28%) TBT(-23%) VXX(-20%) XLU(-10%) VIXM(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.065% (StdDev 2.13%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $63.04(-6.36%) | Resistance Level | $69.36 | 5 Day Moving Average | $67.34(-0.03%) | 10 Day Moving Average | $67.82(-0.74%) | 20 Day Moving Average | $69.36(-2.94%) | To recent high | -15.5% | To recent low | 1.1% | Market Cap | $1.082b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |